for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Newlink genetics announces FDA orphan-drug designation for Indoximod

Oct 30 (Reuters) - Newlink Genetics Corp

* Newlink Genetics announces FDA orphan-drug designation for Indoximod

* Indoximod was granted orphan-drug designation by U.S. FDA for treatment of patients with stage IIB-IV melanoma Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up